US 7,572,590 B2
	Method for the diagnosis of sepsis with determination of CA 19-9
Andreas Bergmann, Berlin (Germany)
Assigned to B.R.A.H.M.S. Aktiengesellschaft, Henningsdorf (Germany)
Appl. No. 10/496,250 PCT Filed Nov. 27, 2002, PCT No. PCT/EP02/13392 § 371(c)(1), (2), (4) Date Nov. 05, 2004, PCT Pub. No. WO03/048777, PCT Pub. Date Jun. 12, 2003.
Claims priority of application No. 01128850 (EP), filed on Dec. 04, 2001.
Prior Publication US 2005/0059104 A1, Mar. 17, 2005
Int. Cl. G01N 33/53 (2006.01); G01N 33/48 (2006.01)

U.S. Cl. 435—7.1  [702/19]

9 Claims

1. A method for assisting in the diagnosis of sepsis, said method comprising testing a biological fluid of a patient who, based on clinical findings, has sepsis-associated symptoms, for an elevated amount of CA19-9 as compared to a control group, wherein an elevated amount of CA19-9 in said sample is indicative of sepsis.